Tumour heterogeneity and clonality - An old theme revisited

Annals of Oncology

Volumn 7, Issue 2, 1996, Pages 121-128

  Fey, M F ^a   Tobler, A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Clonal evolution; Clonality; Molecular tumour markers; Tumour heterogeneity

Indexed keywords

TUMOR MARKER;

CANCER; CANCER CELL POPULATION HETEROGENEITY; CELL CLONE; PRIORITY JOURNAL; REVIEW;

EID: 0029963179     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010537     Document Type: Review

References (88)

1. Nowell P.C. Mechanisms of tumor progression Cancer Res 46 1986 2203 2207
2. Rabbitts T.H. Chromosomal translocations in human cancer Nature 372 1994 143 149
3. Wainscoat J.S. Fey M.F. Assessment of clonality in human tumours: A review Cancer Res 50 1990 1355 1360
4. Fidler I.J. Hart I.R. Biological diversity in metastatic neoplasms: Origins and implications Science 217 1982 998 1003
5. Talmadge J.E. Wolman S.R. Fidler I.J. Evidence for the clonal origin of spontaneous metastases Science 217 1982 361 363
6. Zetter B.R. The cellular basis of site-specific tumor metastases N Engl J Med 322 1990 605 612
7. Fidler I.J. Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor Science 197 1977 893 895
8. bcr/abl gene of the Philadelphia chromosome Science 247 1990 824 830
9. Voncken J.W. Morris C. Pattengale P. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice Blood 79 1992 1029 1036
10. Vogelstein B. Fearon E.R. Hamilton S.R. Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
11. Sugimura T. Multistep carcinogenesis: A 1992 perspective Science 258 1992 603 607
12. Cheng K.C. Loeb L.A. Genomic instability and tumor progression: Mechanistic considerations Adv Cancer Res 60 1993 121 155
13. Woodruff M.F.A. Ansell J.D. Forbes G.M. Clonal interaction in rumours Nature 299 1982 822 824
14. Woodruff M.F.A. Tumor clonality and its biological significance Adv Cancer Res 50 1988 197 229
15. Fey M.F. Hesketh C. Wainscoat J.S. Clonal allele loss in gastrointestinal cancers Br J Cancer 59 1989 750 754
16. Sidransky D. Frost P. Von Eschenback A. Clonal origin of bladder cancer N Engl J Med 326 1992 737 740
17. Miyao N. Tsai Y.C. Lerner S.P. Role of chromosome 9 in human bladder cancer Cancer Res 53 1993 4066 4070
18. Mok C.-H. Tsao S.W. Knapp R.C. Unifocal origin of advanced human epithelial ovarian cancers Cancer Res 52 1992 5119 5122
19. Tsao S. Mok S.C.H. Knapp R.C. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas Gynecol Oncol 48 1993 5 10
20. Fey M.F. Wells R.A. Wainscoat J.S. Assessment of clonality in gastrointestinal cancer by DNA fingerprinting J Clin Invest 82 1988 1532 1537
21. Boltz E.M. Hamett P. Leary J. Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting Br J Cancer 62 1990 23 27
22. Muto M.G. Welch W.R. Mok S.C.H. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum Cancer Res 55 1995 490 492
23. Oda T. Tsuda H. Scarpa A. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma Cancer Res 52 1992 3674 3678
24. Sheu J.C. Huang G.T. Chou H.C. Multiple hepatocellular carcinomas at the early stage have different clonality Gastro-enterology 105 1993 1471 1476
25. Radford D.M. Philips N.J. Fair K.L. Allelic loss and the progression of breast cancer Cancer Res 55 1995 5180 5183
26. Tsuda H. Hirohashi S. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q Cancer Res 55 1995 3395 3398
27. Noguchi S. Aihara T. Koyama H. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis Cancer 74 1994 872 877
28. Fey M.F. Peter H.J. Hinds H.L. Clonal analysis of human tumours with M27ß, a highly informative polymorphic X-chromosomal probe J Clin Invest 89 1992 1438 1444
29. Zhuang Z. Merino M.J. Chuaqui R. Identical allelic loss on chromosome 11q13 in micro-dissected in situ and invasive human breast cancer Cancer Res 55 1995 467 471
30. Chadburn A. Cesarman E. Liu Y.F. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms Cancer 75 1995 2747 2756
31. Shearer W.T. Ritz J. Finegold M.J. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency N Engl J Med 312 1985 1151 1159
32. Kaplan M.A. Ferry J A. Harris N.L. Jacobson J.O. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers Am J Clin Pathol 101 1994 590 596
33. Cleary M.L. Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas Lancet 11 1984 489 493
34. Cleary M.L. Nalesnik M.A. Shearer W.T. Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure on the genomic termini of the Epstein-Barr virus Blood 72 1988 349 352
35. Borisch B. Gatter K.C. Tobler A. Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients Am J Clin Pathol 98 1992 312 318
36. Raab-Traub N. Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation Cell 47 1986 883 889
37. Hummel M. Ziemann K. Lammert H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Stern-berg cells N Engl J Med 333 1995 901 906
38. Jen J. Kim H. Piantadosi S. Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 1994 213 221
39. Nagel S. Borisch B. Thein S.L. Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intra-tumor heterogeneity in gastrointestinal cancers Cancer Res 55 1995 2866 2870
40. Bronner C.E. Baker S.M. Morrison P.T. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer Nature 368 1994 258 261
41. Fishel R. Lescoe M.X. Rao M.R.S. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer Cell 75 1993 1027 1038
42. Leach F.S. Nicolaides N.C. Papdopoulos N. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer Cell 75 1993 1215 1225
43. Nicoloides N.C. Papdopoulos N. Liu B. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer Nature 371 1994 75 80
44. Mao L. Lee D.J. Tockman M.S. Microsatellite alterations as clonal markers for the detection of human cancer Proc Natl Acad Sci 91 1994 9871 9875
45. Fey M.F. Zimmermann A. Borisch B. Tobler A. Studying clonal heterogeneity in human cancers Cancer Res 53 1993 921
46. Ookawa K. Sakamoto M. Hirohashi S. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma Int J Cancer 53 1993 382 387
47. Sakr W.A. Macoska J.A. Benson P. Allelic loss in locally metastatic, multisampled prostate cancer Cancer Res 54 1994 3273 3277
48. Emmert-Buck M.R. Vocke C.D. Pozzatti R.O. Allelic loss on chromosome 8pl2–21 in microdissected prostatic intra-epithelial neoplasia Cancer Res 55 1995 2959 2962
49. Egawa S. Uchida T. Suyama K. Genomic instability of microsatellite repeats in prostate cancer Relationship to clini-copathological variables Cancer Res 55 1995 2418 2421
50. Sawyers C.L. Timson L. Kawasaki E. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction Proc Natl Acad Sci USA 87 1990 563 567
51. Morgan G.J. Hughes T. Janssen J.W.G. Polymerase chain reaction for detection of residual leukaemia Lancet I 1989 928 929
52. Lo Coco F. Diverio D. pandolfi P.P. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia Lancet 340 1992 1437 1438
53. Diverio D. Pandolfi P.P. Biondi A. Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long term remission Blood 82 1993 3556 3559
54. Warrell R.P. de Thé H. Wang Zy Degos L. Acute promyelocytic leukemia N Engl J Med 329 1993 177 189
55. Huang W. Sun Gl Li X.S. Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/ polymerase chain reaction to predict relapse Blood 82 1993 1264 1269
56. Yokota S. Hansen-Hagge T.E. Ludwig W.D. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients Blood 77 1991 331 339
57. Yamada M. Wasserman R. Lange B. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment N Engl J Med 323 1990 448 455
58. Beishuizen A. Hählen K. van Wering E.R. van Dongen J.J.M. Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction N Engl J Med 324 1991 772 775
59. Breit T. Wolvers-Tettero I.L.M. Hählen K. Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemias: Implication for the detection of minimal residual disease Leukemia 5 1991 1076 1086
60. Hansen-Hagge T.E. Yokota S. Bartram C.R. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor δ chain sequences Blood 74 1989 1762 1767
61. Taylor J.J. Rowe D. Williamson I.K. Detection of T-cell receptor γ chain V gene rearrangements using the polymrase chain reaction: Application to the study of clonal disease cells in acute lymphoblastic leukemia Blood 77 1991 1989 1995
62. Jonsson O.G. Kitchens R.L. Scott F.C. Graham-Smith R. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes Blood 76 1990 2072 2079
63. D'Auriol L. Macintyre E. Galibert F. Sigaux F. In vitro amplification of T-cell γ gene rearrangements: A new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias Leukemia 3 1989 155 158
64. Biondi A. Yokota S. Hansen-Hagge T.E. Minimal residual disease in childhood acute lymphoblastic leukemia: Analysis of patients in continuous complete remission or with consecutive relapse Leukemia 6 1992 282 288
65. Brisco M.J. Concon J. Hughes E. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction Lancet 343 1994 196 200
66. van Dongen J.J.M. Breit T. Adriaansen H.J. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction Leukemia 6 Suppl 1 1992 47 59
67. Beishuizen A. Hählen K. Hagemeijer A. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin Leukemia 5 1991 657 667
68. Breit T.M. Wilvers-Tettero I.L.M. Hahlen K. Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemias: Implications for the detection of minimal residual disease Leukemia 5 1991 1076 1086
69. Busque L. Gilliland D.G. Clonal evolution in acute myeloid leukemia Blood 82 1993 337 342
70. Foti A. Cline M.J. Sequential relapses of blast crisis may involve different clones of cells with different molecular abnormalities Br J Haematol 87 1994 627 630
71. Siegelman M.H. Cleary M.L. Warnke R. Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms J Exp Med 161 1985 850 863
72. Taylor J.J. Rowe D. Kylefjord H. Characteristion of non-concordance in the T-cell receptor γ chain genes at presentation and clinical relapse in acute lymphoblastic leukemia Leukemia 8 1994 60 66
73. Hakim I. Rechavi G. Brok-Simoni F. Analysis of rearranged immunoglobulin genes indicating a process of clonal evolution in chronic lymphocytic leukaemia Br J Haematol 84 1993 436 442
74. Cleary M.L. Meeker T.C. Levy S. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B-cell lymphoma Cell 44 1986 97 106
75. Friedman D.F. Cho E.A. Goldman J. The role of clonal selection in the pathogenesis of an autoreactie human B-cell lymphoma J Exp Med 174 1991 525 537
76. Kon S. Levy S. Levy R. Retention of an idiotypic determinant in a human B-cell lymphoma undergoing immunoglobulin variable-region mutation Proc Natl Acad Sci 84 1987 5053 5057
77. Cleary M.L. Galili N. Trela M. Single cell origin of bigenotypic and biphenotypic B-cell proliferations in human follicular lymphomas J Exp Med 167 1988 582 597
78. Zelenetz A.D. Chen T.T. Levy R. Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B-cell J Exp Med 173 1991 197 207
79. Zhu D. Hawkins R.E. Hamblin T.J. Stevenson F.K. Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes Br J Haematol 86 1994 505 512
80. Pistoia V. Roncella S. Di Celle P.F. Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: Evidence for the single-cell origin of the two tumors Blood 78 1991 797 804
81. Wickert R.S. Weisenburger D.D. Tierens A. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage Blood 86 1995 2312 2320
82. Sidransky D. Mikkelsen T. Schwechheimer K. Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature 355 1992 846 847
83. Fults D. Brockmeyer D. Tullous M.W. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression Cancer Res 52 1992 674 679
84. Leenstra S. Troost D. Westerveld A. Molecular characterization of areas with low grade rumor or satellitosis in human malignant astrocytomas Cancer Res 52 1992 1568 1572
85. Fey M.F. Kulozik A.E. Hansen-Hagge T.E. Tobler A. The polymerase chain reaction: A new tool for the detection of minimal residual disease in haematological malignancies Eur J Cancer 27 1991 89 94
86. Fey M.F. Tobler A. Cancer diagnosis by molecular genetic probes: The present and the promise Ann Oncol 2 1991 629 633
87. Karp J.E. Broder S. New directions in molecular medicine Cancer Res 54 1994 653 665
88. Karp J.E. Broder S. Molecular foundations of cancer: New targets for intervention Nature Med 1 1995 309 320